Top Medical News
Jackey Suen, Yesterday

The addition of sildenafil to nintedanib provides no improvements in health-related quality of life (HRQoL) in patients with idiopathic pulmonary fibrosis (IPF), according to results of the INSTAGE study presented at the 28th European Respiratory Society International Congress 2018 (ERS 2018).

4 days ago
Results of a recent study have shown the validity and reliability of the St George’s Respiratory Questionnaire (SGRQ) as a sensitive measure for capturing health-related quality of life (HRQoL) in patients with connective tissue disease-associated interstitial lung disease (CTD-ILD).
4 days ago
Patients with malignant airway obstruction (MAO) appear to have better survival with combination therapy with stenting plus external beam radiotherapy (EBRT) compared to stenting or EBRT alone, according to the results of a retrospective analysis.
4 days ago
High-grade adverse event (AEs) are relatively common in elderly adults with advanced or metastatic nonsmall cell lung cancer (NSCLC) treated with nivolumab in routine practice, a recent investigation has shown.
Dr. Joseph Delano Fule Robles, 4 days ago

Digital mindfulness is an acceptable nonpharmacological intervention that can be integrated with existing treatment for patients with asthma to improve quality of life, according to a study from the UK reported at the recent European Respiratory Society (ERS) International Congress 2018.

Christina Lau, 4 days ago

The anti–interleukin-5 (anti–IL-5) agent reslizumab significantly improves disease control and lung function and reduces the need for oral steroid maintenance therapy in patients with severe eosinophilic asthma, results of a real-life study have shown.

Christina Lau, 4 days ago

Interstitial lung abnormalities (ILA), a common finding in low-dose chest CT, are associated with a 5.5-fold increase in risk of lung cancer over long-term follow-up, according to a study reported at the European Respiratory Society (ERS) International Congress 2018.

Special Reports
02 Aug 2018
At a dinner symposium at Le Méridien Kuala Lumpur, Professor Dato’ Prepageran Narayanan presented the data concerning allergic rhinitis (AR) in Malaysia, and he discussed the role of intranasal corticosteroids (INCSs) in managing AR.
Prof. Giuseppe Mancia, Prof. Jong-Won Ha, Prof. Lin Jiunn-Lee, 11 Jul 2018
Hypertension guidelines differ in their recommendation to use beta-blockers as first-line agents. At a Menarini-sponsored symposium held during the Asian Pacific Society of Cardiology Congress 2018 in Taipei, Taiwan, Professor Giuseppe Mancia from the University of Milano-Bicocca in Milan, Italy and Professor Jong-Won Ha from the Yonsei University College of Medicine in Seoul, Korea discussed the rationale behind these recommendations, and reviewed the role of beta-blockers in hypertension management, particularly the role of vasodilatory beta-blocker nebivolol (Nebilet®, Menarini). Professor Lin Jiunn-Lee, APSC 2018 chairman and president of the Taiwan Society of Cardiology, chaired the symposium.
01 Jul 2018
Airway diseases – such as chronic obstructive pulmonary disease and obstructive sleep apnoea – have a significant impact on one’s health, quality of life and daily functioning. This article discusses how technological advancements in non-invasive ventilation and home sleep testing systems help to improve patient care and outcomes.
01 May 2018
SPIOLTO RESPIMAT - Tiotropium 2.5 mcg, Olodaterol 2.5 mcg inhalation soln - Boehringer Ingelheim
22 Jan 2018
During the recent 2017 Engelhard-Delfi Conference, organized by Delfi Marketing Sdn Bhd, three renowned speakers shared their insights into paediatric respiratory medicine.
22 Jan 2018
Literature suggests that IPF is either the first or second most common interstitial lung disease (ILD) in pulmonology practice, with prevalence ranging from 17–86%. At the recent 3rd Respiratory Forum organized by Boehringer Ingelheim, Dr Felix Chua shared his insights into the importance of advancing the treatment paradigm of IPF, and the role of nintedanib (OFEV®) in its management.
05 Jan 2018
At a recent dinner symposium at Shangri-La Kuala Lumpur, Dr Omar Usmani discussed the importance of inhaler devices in the management of asthma and chronic obstructive pulmonary disease (COPD).
Conference Reports
Jackey Suen, 22 Sep 2018

The addition of sildenafil to nintedanib provides no improvements in health-related quality of life (HRQoL) in patients with idiopathic pulmonary fibrosis (IPF), according to results of the INSTAGE study presented at the 28th European Respiratory Society International Congress 2018 (ERS 2018).

Dr. Joseph Delano Fule Robles, 19 Sep 2018

Digital mindfulness is an acceptable nonpharmacological intervention that can be integrated with existing treatment for patients with asthma to improve quality of life, according to a study from the UK reported at the recent European Respiratory Society (ERS) International Congress 2018.

Christina Lau, 19 Sep 2018

The anti–interleukin-5 (anti–IL-5) agent reslizumab significantly improves disease control and lung function and reduces the need for oral steroid maintenance therapy in patients with severe eosinophilic asthma, results of a real-life study have shown.

Christina Lau, 19 Sep 2018

Interstitial lung abnormalities (ILA), a common finding in low-dose chest CT, are associated with a 5.5-fold increase in risk of lung cancer over long-term follow-up, according to a study reported at the European Respiratory Society (ERS) International Congress 2018.

Roshini Claire Anthony, 07 Jun 2018

Prescribing antibiotics despite no indication of infection to patients hospitalized with asthma was associated with longer hospital stay, a higher risk of antibiotic-related diarrhoea, and elevated hospitalization costs, according to a study presented at the recent American Thoracic Society conference (ATS 2018).

Elaine Soliven, 06 Jun 2018
Women with endometriosis may have a higher risk of asthma compared with women without endometriosis, according to a study presented at ATS 2018.
Elvira Manzano, 05 Jun 2018
The notion that overweight patients with COPD* seems to have a reduced risk of mortality vs those who are of normal weight, or that fat alters outcomes in obese patients – a phenomenon called “obesity paradox” – does not hold true if BMI is >40 kg/m2, a study has shown.
CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download